title: Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease.
abstract: Pick's disease is a subset of fronto-temporal dementia characterised by severe atrophy of the temporal and frontal lobes due to marked neuronal loss accompanied by astrocytic gliosis enriched in glial acidic protein. The remaining neurones have intracytoplasmic inclusions composed of hyperphosphorylated tau, called Pick bodies, in addition to hyperphosphorylated tau in astrocytes and oligodendrocytes. Gel electrophoresis and western blotting using markers of glycoxidation (advanced glycation end products, N-carboxyethyl-lysine and N-carboxymethyl-lysine: AGE, CEL, CML, respectively) and lipoxidation (4-hydroxy-2-nonenal: HNE, and malondialdehyde-lysine: MDAL) were used in the frontal and occipital cortex in three Pick's disease cases and three age-matched controls. In Pick's disease, increased AGE, CML, CEL, HNE and MDAL bands of about 50 kDa were observed in the frontal cortex (but not in the occipital cortex) in association with increased density of glial acidic protein bands. Bi-dimensional gel electrophoresis and western blotting also disclosed increased amounts and numbers of glial acidic protein isoforms in the frontal cortex in Pick's disease. Moreover, redox proteomics showed glycoxidation, as revealed with anti-CEL antibodies and lipoxidation using anti-HNE antibodies, of at least three glial acidic protein isoforms. The present results demonstrate that glial acidic protein is a target of oxidative damage in the frontal cortex in Pick's disease.
authors.affiliation: Institut de Neuropatologia, Servei Anatomia Patològica, IDIBELL-Hospital Universitari de Bellvitge, Universitat de Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
authors.forename: G
authors.initials: G
authors.lastname: Muntané
authors.forename: E
authors.initials: E
authors.lastname: Dalfó
authors.forename: A
authors.initials: A
authors.lastname: Martínez
authors.forename: M J
authors.initials: MJ
authors.lastname: Rey
authors.forename: J
authors.initials: J
authors.lastname: Avila
authors.forename: M
authors.initials: M
authors.lastname: Pérez
authors.forename: M
authors.initials: M
authors.lastname: Portero
authors.forename: R
authors.initials: R
authors.lastname: Pamplona
authors.forename: V
authors.initials: V
authors.lastname: Ayala
authors.forename: I
authors.initials: I
authors.lastname: Ferrer
mesh_terms: D000447:Aldehydes / Q000494:pharmacology; D001344:Autopsy; D001921:Brain / Q000473:pathology*; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism*; D006031:Glycosylation; D006801:Humans; D008055:Lipids; D008279:Magnetic Resonance Imaging; D013058:Mass Spectrometry; D009419:Nerve Tissue Proteins / Q000378:metabolism; D018384:Oxidative Stress; D020774:Pick Disease of the Brain / Q000378:metabolism*; D012016:Reference Values; D014057:Tomography, X-Ray Computed
chemical_list: D000447:Aldehydes; D005904:Glial Fibrillary Acidic Protein; D008055:Lipids; D009419:Nerve Tissue Proteins; C027576:4-hydroxy-2-nonenal